Hi Everyone, I wanted to drop you a quick note to let you know that I am now the "community expert" for the AMN community. I look forward to working with this community to answer any questions and point our members towards interesting and worthwhile research about AMN. Please feel free to communicate with me by using the "Community Expert" link on the left of this page. Best regards, David

Can you update us on the status of RPI-78M?

Hi Guys, Thanks for your replies. For a little more about my background, feel free to click on my username ("biotechguy":http://rareshare.org/users/biotechguy). I'm one of the co-founders of RareShare and AMN is specifically what led me to create the site. Also, my "corporate profile" can be accessed on my "company's website":http://www.nutrapharma.com/corporate_overview/corporate_governance.php#isserman Also,to Chris: I'd be happy to give an update on RPI-78M, but would you mind asking that question on the community expert page so I can make sure to share it with everyone? Best regards, David

David, I posted my question to the community expert page. Please let me know if you did not get it. Thanks.

Hi David, I also posted a question on the community expert page. Did you get it? Deo

Check it out. Here's the latest. Follow the two links. http://www.youtube.com/NationalMSSociety#p/u/43/8E7DUwkAQv4 http://nationalmssociety.org/news/news-detail/index.aspx?nid=2586 Read on... Britt

Britt, Ampyra is actually a different drug than the one I am referring to, RPI-78M. However, ampyra does appear to have a lot of promise, and I look forward to trying it.